C. Nourse

发表

Whole genomes redefine the mutational landscape of pancreatic cancer

J. Kench, J. Pearson, D. Aust, 2015, Nature.

Whole-genome landscape of pancreatic neuroendocrine tumours

Shivashankar H. Nagaraj, R. Gibbs, D. Wheeler, 2017, Nature.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Lincoln D. Stein, Andrew M. K. Brown, D. Pai, 2012, Nature.

Genomic analyses identify molecular subtypes of pancreatic cancer

R. Gibbs, D. Mukhopadhyay, D. Wheeler, 2016, Nature.

Whole–genome characterization of chemoresistant ovarian cancer

Joshy George, Andrew Lonie, Matthew Anderson, 2015, Nature.

Somatic Point Mutation Calling in Low Cellularity Tumors

Jianmin Wu, Matthew Anderson, Peter J. Wilson, 2013, PloS one.

Dual targeting of p53 and c-Myc selectively eliminates leukaemic stem cells

Karen Dunn, Andrew Pierce, Koorosh Korfi, 2016, Nature.

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

A. Ashworth, D. Mukhopadhyay, C. Pilarsky, 2020, Gastroenterology.

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

A. Ashworth, D. Mukhopadhyay, Robert Brown, 2020, Cell reports.

Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis.

Rohan Williams, C. Nourse, A. Cunningham, 2009, Tuberculosis.

A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencing.

J. Pearson, A. Biankin, N. Waddell, 2014, BioTechniques.

Hypermutation In Pancreatic Cancer.

J. Kench, J. Pearson, C. Pilarsky, 2017, Gastroenterology.

Nones, K. et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-

J. Pearson, A. Biankin, M. Pajic, 2014 .

DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency

Martin A. M. Reijns, J. Rosenfeld, Sancha Martin, 2018, American journal of human genetics.

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance

J. Pearson, S. Lakhani, N. Waddell, 2015, The Journal of pathology.

Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis

D. Adams, A. Biankin, S. Barry, 2019, Cancer cell.

Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling

Jianmin Wu, Amber Johns, Stephen Kazakoff, 2014, International journal of cancer.

Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis

Peter J. Campbell, Matthew Anderson, Sean M. Grimmond, 2014, Nature Communications.

Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer

Joshy George, Andrew Lonie, Matthew Anderson, 2015, Nature.

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

A. Ashworth, D. Mukhopadhyay, C. Pilarsky, 2019, bioRxiv.

Copy-number signatures and mutational processes in ovarian carcinoma

Oliver Hofmann, David Millan, Florian Markowetz, 2017, Nature Genetics.

Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing

Sancha Martin, E. Tobias, A. Biankin, 2022, European Journal of Human Genetics.

Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system

P. Gunning, C. Nourse, P. Basset, 1998, Oncogene.

Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.

C. Nourse, M. Mattei, S. H. Wilson, 2001, Genomics.

Cloning of a third member of the D52 gene family indicates alternative coding sequence usage in D52-like transcripts.

P. Gunning, C. Nourse, M. Mattei, 1998, Biochimica et biophysica acta.

Unraveling Heterogeneity in the Aging Hematopoietic Stem Cell Compartment: An Insight From Single-cell Approaches

C. Nourse, K. Kirschner, G. Helgason, 2023, HemaSphere.

Copy-number signatures and mutational processes in ovarian carcinoma

F. Markowetz, M. Jimenez-Linan, J. Brenton, 2017, Nature Genetics.

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Mithat Gönen, Katherine M. Tucker, Jedd D. Wolchok, 2017, Nature.

Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

Katherine Sellers, S. Barry, C. Nourse, 2023, Nature Metabolism.

Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours

Shivashankar H. Nagaraj, R. Gibbs, D. Wheeler, 2017, Nature.

ecDNA amplification of MYC drives intratumor copy-number heterogeneity and adaptation to stress in PDAC

D. Tuveson, C. Luchini, C. Nourse, 2023, bioRxiv.

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance

J. Pearson, S. Lakhani, N. Waddell, 2015, The Journal of pathology.

Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling

J. Pearson, A. Biankin, M. Pajic, 2014, International journal of cancer.

Hypermutation In Pancreatic Cancer.

J. Kench, J. Pearson, C. Pilarsky, 2017, Gastroenterology.